{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:12:39Z","timestamp":1793103159344,"version":"4.5.0"},"reference-count":23,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vector-Borne and Zoonotic Diseases"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe and the incidence of LB is increasing owing to an expansion in tick habitats. However, LB surveillance is quite heterogeneous across the continent, and for those countries with publicly available data, it is difficult to understand the differences in incidence between countries. The objective of our study was to summarize the publicly available data from surveillance for LB in the form of surveillance reports and\/or dashboards and to compare the information available for various countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We identified publicly available LB data (online dashboards and surveillance reports) in the European Union, European Economic Area, the United Kingdom, Russia, and Switzerland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 36 countries studied, 28 had LB surveillance in place; 23 had surveillance reports, and 10 had dashboards. The dashboards, in general, had more granular data compared with the surveillance reports, but the reports covered longer time periods. LB annual cases, incidence, age, and sex-stratified LB data; manifestations; and regional data were available for most of the countries. LB case definitions varied significantly among the countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study highlights large differences in LB surveillance systems, including representativeness, case definitions, type of data available that might inhibit comparison of data between countries and accurate determination of burden of disease, and risk groups within countries. Standardization of case definitions across countries would be a useful first step enabling comparisons between countries and contribute to recognizing the true burden of LB in Europe.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/vbz.2022.0067","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T11:44:14Z","timestamp":1681818254000},"page":"142-155","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":48,"title":["The Landscape of Lyme Borreliosis Surveillance in Europe"],"prefix":"10.1177","volume":"23","author":[{"given":"Archana","family":"Nagarajan","sequence":"first","affiliation":[{"name":"P95 Epidemiology &amp; Pharmacovigilance, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozica","family":"Skufca","sequence":"additional","affiliation":[{"name":"P95 Epidemiology &amp; Pharmacovigilance, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vyse","sequence":"additional","affiliation":[{"name":"Vaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pilz","sequence":"additional","affiliation":[{"name":"Pfizer Global Medical Affairs, Vaccines, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[{"name":"Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Riera-Montes","sequence":"additional","affiliation":[{"name":"P95 Epidemiology &amp; Pharmacovigilance, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[{"name":"Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-876X","authenticated-orcid":false,"given":"James H.","family":"Stark","sequence":"additional","affiliation":[{"name":"Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9554.1000330"},{"key":"e_1_3_6_3_1","unstructured":"Centers for Disease Control and Prevention. Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guidelines Working Group. 2001. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5013a1.htm [Last accessed: August 10 2021]."},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184357"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocab004"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.027"},{"key":"e_1_3_6_7_1","unstructured":"European Center for Disease Prevention and Control. ECDC Comment: European Commission Updates Communicable Disease Surveillance List\u2014Lyme Neuroborreliosis Now Under EU\/EEA Surveillance. 2018. Available from: https:\/\/www.ecdc.europa.eu\/en\/news-events\/ecdc-comment-european-commission-updates-communicable-disease-surveillance-list-lyme [Last accessed: June 15 2021]."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.025"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz872"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031816-044348"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1041"},{"key":"e_1_3_6_12_1","unstructured":"Lindgren E Jaenson TGT Menne B et al. Lyme Borreliosis in Europe: Influences of Climate and Climate Change Epidemiology Ecology and Adaptation Measures. WHO Regional Office for Europe: Copenhagen; 2006."},{"key":"e_1_3_6_13_1","unstructured":"Lorenc T Jones-Diette J Blanchard L et al. EPPI-Centre Social Science Research Unit UCL Institute of Education University College London. Incidence and Surveillance of Lyme Disease: Systematic Review and Policy Mapping. London UK; 2017. Available from: https:\/\/eppi.ioe.ac.uk\/CMS\/Portals\/0\/PDF%20reviews%20and%20summaries\/Lyme%20disease%20surveillance%202017%20Lorenc.pdf [Last accessed: November 23 2021]."},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2007.12.011"},{"key":"e_1_3_6_15_1","doi-asserted-by":"crossref","unstructured":"Nsubuga P White ME Thacker SB et al. Public Health Surveillance: A Tool for Targeting and Monitoring Interventions. In: Disease Control Priorities in Developing Countries. (Jamison DT Breman JG Measham AR et al. eds.) The International Bank for Reconstruction and Development\/The World Bank: Washington DC; 2006; pp. 997\u20131016.","DOI":"10.1596\/978-0-8213-6179-5\/Chpt-53"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/0960085X.2020.1793698"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144843"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03175.x"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60103-7"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.077"},{"key":"e_1_3_6_21_1","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe","volume":"39","author":"Sykes RA","year":"2017","unstructured":"Sykes RA, , Makiello P. An estimate of Lyme borreliosis incidence in Western Europe. J Public Health, 2017; 39:74-81.","journal-title":"J Public Health"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31738-0"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.27.30569"},{"key":"e_1_3_6_24_1","unstructured":"World Health Organization. WHO Report on Global Surveillance of Epidemic-Prone Infectious Diseases. World Health Organization: Geneva; 2000."}],"container-title":["Vector-Borne and Zoonotic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/vbz.2022.0067","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/vbz.2022.0067","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/vbz.2022.0067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:02:16Z","timestamp":1777590136000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/vbz.2022.0067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1089\/vbz.2022.0067"],"URL":"https:\/\/doi.org\/10.1089\/vbz.2022.0067","relation":{},"ISSN":["1530-3667","1557-7759"],"issn-type":[{"value":"1530-3667","type":"print"},{"value":"1557-7759","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}